HZNP..$3.61 Horizon Pharma announced that it has entered into a loan agreement with a group of lenders to provide $60 mln in capital (HZNP) 3.10 -0.19 : CO used $22.4 mln of the loan proceeds to repay the remaining obligations under its loan agreements with Oxford Finance LLC, Silicon Valley Bank and Kreos Capital, and expects to use the remainder of the capital to fund the ongoing commercial launch of DUEXIS in the U.S., and to pursue regulatory approval for DUEXIS in Europe and LODOTRA in the U.S.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.